Leveraging COVID-19 vaccine allergy evaluations with coincident drug allergy delabelling: Effectiveness and impact on quality of life
Services evaluating COVID-19 vaccine allergies have not only empowered individuals labelled with drug allergy to receive vaccinations safely, but have also enhanced access to drug allergy delabeling services for the general public.
Authors
- Valerie Chiang (ORCID: https://orcid.org/0000-0001-9250-967X)
- Philip Hei Li (ORCID: https://orcid.org/0000-0002-9155-9162)
- Jackie S. H. Yim
- Andy Ka Chun Kan (ORCID: https://orcid.org/0000-0002-1943-2562)
- Hugo W. F. Mak (ORCID: https://orcid.org/0000-0001-5085-0837)
- Weihong Shi
Institutions
- Queen Mary Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Vaccine
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1016/j.vaccine.2025.126849
- Citations
- 5
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 6.97
Funders
- Health and Medical Research Fund